Clinical Trials Browser

Triple Negative Breast Neoplasms × Simvastatin × Clear all

NCT05550415 2024-10-03

The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms